TARDBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.408100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.673770E-01
Normal-vs-Stage2
3.870300E-02
Normal-vs-Stage3
9.628200E-02
Normal-vs-Stage4
5.078000E-01
Stage1-vs-Stage2
8.955400E-01
Stage1-vs-Stage3
2.242800E-01
Stage1-vs-Stage4
3.303000E-01
Stage2-vs-Stage3
1.056990E-01
Stage2-vs-Stage4
2.941400E-01
Stage3-vs-Stage4
8.151800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.426200E-02
Normal-vs-AfricanAmerican
3.791600E-01
Normal-vs-Asian
7.959700E-02
Caucasian-vs-AfricanAmerican
4.498200E-01
Caucasian-vs-Asian
6.923600E-01
AfricanAmerican-vs-Asian
4.291800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.340200E-02
Normal-vs-Female
4.945700E-02
Male-vs-Female
8.536000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.535200E-01
Normal-vs-Age(41-60Yrs)
1.200590E-01
Normal-vs-Age(61-80Yrs)
2.463700E-02
Normal-vs-Age(81-100Yrs)
2.746400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.255600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.229200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.150000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.701230E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.937700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.765600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.694100E-02
Normal-vs-Daily Drinker
6.554500E-02
Normal-vs-Weekly Drinker
3.316400E-02
Normal-vs-Occasional Drinker
4.721600E-01
Normal-vs-Social Drinker
3.483400E-01
Non Drinker-vs-Daily Drinker
6.816800E-01
Non Drinker-vs-Weekly Drinker
9.803800E-01
Non Drinker-vs-Occasional Drinker
4.516500E-02
Non Drinker-vs-Social Drinker
3.804000E-01
Daily Drinker-vs-Weekly Drinker
7.225600E-01
Daily Drinker-vs-Occasional Drinker
1.072170E-01
Daily Drinker-vs-Social Drinker
6.221400E-01
Weekly Drinker-vs-Occasional Drinker
3.593900E-02
Weekly Drinker-vs-Social Drinker
3.493400E-01
Occasional Drinker-vs-Social Drinker
2.104400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.627000E-01
Normal-vs-Grade 2
6.859200E-01
Normal-vs-Grade 3
6.575800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.085600E-01
Grade 1-vs-Grade 3
1.028800E-01
Grade 1-vs-Grade 4
7.627000E-01
Grade 2-vs-Grade 3
4.009200E-01
Grade 2-vs-Grade 4
6.859200E-01
Grade 3-vs-Grade 4
6.575800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.268300E-02
Normal-vs-NonDiabetic
2.566000E-02
Diabetic-vs-NonDiabetic
4.129000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.561400E-01
Normal-vs-NoPancreatitis
2.792000E-02
Pancreatitis-vs-NoPancreatitis
4.708200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.693700E-02
Normal-vs-N1
3.940400E-02
N0-vs-N1
7.602600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.928000E-01
Normal-vs-TP53-NonMutant
5.757900E-02
TP53-Mutant-vs-TP53-NonMutant
1.380220E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
